Attached files
| file | filename |
|---|---|
| 8-K - 100125_IMX_FORM 8K_INDIA ORDER PR AND CONFERENCE - SECURE POINT TECHNOLOGIES INC | imxform8k_100125.htm |
| EX-99.1 - 100125_IMX_FORM 8K_EX 99.1 - SECURE POINT TECHNOLOGIES INC | imxform8k_ex99-1.htm |
Exhibit
99.2
IMPLANT
SCIENCES AWARDED $6 MILLION CONTRACT
FOR
ITS QUANTUM SNIFFER™ QS-H150 EXPLOSIVES DETECTORS
************
Good
afternoon, my name is Jeff Tehan, Vice President of Marketing and Sales for
Implant Sciences Corporation. Before we get started this afternoon, I have a
little house keeping to attend to regarding Safe Harbors.
Safe
Harbor Statement
This
presentation may contain certain “forward-looking statements,” as that term is
defined in the Private Securities Litigation Reform Act of 1995. Such statements
are based on management’s current expectations and are subject to risks and
uncertainties that could cause the Company’s actual results to differ materially
from the forward-looking statements. These forward-looking statements are based
on management’s beliefs as well as assumptions made by us using currently
available information. Forward-looking statements include, without
limitation, statements containing such words as “anticipate,” “believe,”
“expect,” “intend,” “will,” “should,” and similar expressions, as they relate to
us, are intended to identify forward-looking statements. Such
statements reflect our current view with respect to future events and are
subject to certain risks and uncertainties and assumptions, and are not
guaranties of future performance. Should one our more of these
uncertainties materialize, or should underlying assumptions prove incorrect,
actual results may vary materially from those
described
in this presentation as anticipated, believed, estimated, expected, intended or
using other similar expressions. Forward-looking statements involve
risk and uncertainty because they relate to events and depend on circumstances
that will occur in the future. There are a number of factors that
could cause actual results and developments to differ materially from those
expressed or implied by such forward-looking statements. Such risks and
uncertainties include, but are not limited to, the risks that we described in
our filings with the Securities and Exchange Commission, including its
most recent Forms 10-K, 10-Q and 8-K. We do not undertake any obligation to
update such forward-looking statements.
Thank
you. Now to start this Press Conference, I would like to introduce Mr. Glenn
Bolduc, President and CEO of Implant Sciences Corporation.
Good
afternoon, thank you for this opportunity today to share some important news. As
mentioned in the introduction, my name is Glenn Bolduc, and I am the Chief
Executive Officer for Implant Sciences Corporation of Wilmington, Massachusetts.
Joining me today are two members of the Company’s Board of Directors. Howard
Safir, former New York City Police Commissioner and Fire Commissioner, and
Robert Liscouski, former Assistant Secretary for Infrastructure Protection
within the Department of Homeland Security.
Implant
Sciences develops, manufactures and sells sophisticated sensors and systems for
Security, Safety, and Defense markets. Our flagship product is the Quantum
Sniffer™ QS-H150 Portable Explosives Detector which uses state-of-the-art Ion
Mobility Spectrometry to accurately detect and identify the presence of a wide
range of explosive residue in minute quantities. These minute quantities are in
the low nanogram range for particulates, and in the parts-per-billion range for
explosives vapor. To put that into perspective, note that one part-per-billion
is equivalent to one second of time in 32 years.
The
Company and its products address a sizable market and continue to capture
greater market share. Since entering the SS&D market in 2005, sales have
increased on a compound annual growth basis at 55% per year. The company’s
current pipeline of activity suggests that we are in position to achieve our
FY2010 revenue projection of $19 million.
I am very
pleased to announce that last Thursday, January 14th,
2010, the Government of India awarded Implant Sciences a contract totaling
approximately $6 million for its Quantum Sniffer™ QS-H150 Portable Explosives
Detectors. The contract also provides for a possible follow-on order worth up to
$3 million within the next year. The QS-H150’s will be used by the Ministry of
Defence (MoD) in Force Protection and Public Safety applications throughout the
country. The Company expects to ship the entire order within the current fiscal
year ending June 30, 2010.
This
contract is significant in many ways. Most importantly, it allows Implant
Sciences to continue to contribute to worldwide anti-terrorism efforts. With
this order, the Indian Ministry of Defence joins over 100 customers in 22
countries around the world utilizing our unique and differentiated technologies.
Our customer list includes air marshalls and airport police, subway and rail
security agencies, local and federal law enforcement authorities, and the
military. The markets we serve include Transportation Security, Aviation
Security, Law Enforcement, Force Protection, Critical Infrastructure Protection,
and Public Safety.
The
Company’s strategy aims to capitalize on the strong, rapidly-growing domestic
and international demand for cost-effective security systems. The drivers for
this growth are in the headlines every day.
We are
also pleased to announce that this award, which represents the largest single
order in Implant Sciences history, is the result of an arduous competitive
evaluation that started over 24 months ago. The competition was comprised of
field trials covering all aspects of operation, maintainability, and service in
a wide variety of rugged real-world environments.
At the
conclusion of these trials, Implant Sciences was the sole contract awardee,
having bested all competitors including some of the largest companies in this
sector. We are extremely proud of this, the validation it represents, and the
follow-on opportunities it creates.
To best
support this contract and others in India and South Asia, Implant Sciences has
partnered with LNG Security Services of Delhi, who will provide warranty and
post-warranty technical support, as well as operator and administrator
training.
The
QS-H150 offers compelling technical, operational, and competitive advantages.
Among the most significant are non-contact sample collection; non-radioactive
ionization; simultaneous detection and identification of explosives particulate
and vapor; continuous self-calibration; and ultra-fast clear down or cycle time.
The substance library of the QS-H150 is the broadest in the industry and
includes not only standard military and commercial explosives, but also a wide
variety of improvised and homemade explosives (IED’s and HME’s) including PETN,
which is the substance used in the Christmas Day bombing attempt of Northwest
Airlines flight #253. The library is also easily expanded as new threats emerge.
These advantages offer an extremely versatile solution, and can be rapidly
deployed to greatly increase the number of items screened, effectively becoming
a force multiplier.
The
innovative and unique core technologies of the QS-H150 are extensible for use in
other applications as well. In development is the QS-H300 Air Cargo Screening
System which was designed specifically to address the challenges presented by
Public Law 110-53 “Implementing Recommendations of the 9/11 Commission Act of
2007” which requires the DHS to establish a system to physically screen 100% of
all air cargo by August of 2010. The QS-H300 is currently ready and awaiting the
start of the TSA’s qualification testing. The Company has also designed and
tested for proof-of-concept additional products for explosives trace screening
of people, baggage and parcels, and cargo and vehicles. For further details on
the Company and its products, please visit the Company's website at
www.implantsciences.com.
At this
time Mr. Safir and Mr. Liscouski will offer their respective thoughts on how
Implant Sciences products offer detection capabilities to meet current and
emerging threats around the world.
Thank you
Bob, thank you Howard. We would now be happy to answer any questions you might
have.
Thank you
very much.